Logo

GATC Installs 454's FLX in its German Sequencing Shop

Mar 06, 2007
NEW YORK (GenomeWeb News) — GATC Biotech installed 454’s Genome Sequencer FLX System in its core lab in Konstanz, Germany, last month, GATC said today.
 
GATC, which reported in January it had purchased the FLX together with a Solexa 1G Genetic Analyzer, said it will use the FLX to focus on “in-depth analysis of whole transcriptomes,” but also will provide customers with all available FLX applications.
 
The company said in January it has pumped $1.5 million worth of sequencing tools into its Konstanz lab, where it will offer sample preparation, sequencing, and bioinformatics services.

Filed under

Clinical Sequencing
Sequencing
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.